MedPath

Observation study for availability of phone support service for management of Capecitabine in patients with Colorectal Cancer(XTRA study)

Not Applicable
Conditions
Colorectal Cancer
Registration Number
JPRN-UMIN000004429
Lead Sponsor
Sapporo City General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1.Uncontrolled Diarrhea 2.Other conditions not suitable for this study

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Safety(grade3 of Hand-Foot Syndrome)
Secondary Outcome Measures
NameTimeMethod
Premature withdrawal rate treatment interruption rates Time to recovery of HFS after interruption Mean cumulative dose Mean treatment duration Compliance duration of phone call
© Copyright 2025. All Rights Reserved by MedPath